US FDA strengthens renal warnings for diabetes products

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2016年 / 1607卷 / 1期

关键词：

D O I：

10.1007/s40278-016-18580-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：6 / 6

相关论文

共 50 条

[41] US FDA restricts use of opioid products for coughs/colds
Reactions Weekly, 2018, 1686 (1) : 9 - 9
[42] US FDA approves menthol e-cigarette products
Furlow, Bryant
LANCET RESPIRATORY MEDICINE, 2024, 12 (09): : 667 - 667
[43] US FDA removes boxed warning from canagliflozin products
Reactions Weekly, 2020, 1820 (1) : 5 - 5
[44] US FDA requires pancreatic insufficiency products to gain approval
Reactions Weekly, 2004, 1000 (1) : 3 - 3
[45] US FDA advises against use of Zicam cold products
Reactions Weekly, 2009, 1257 (1) : 3 - 3
[46] HeidelbergCement strengthens involvement in the US
不详
ZKG INTERNATIONAL, 2004, 57 (12): : 9 - 9
[47] Euro strengthens, US$ weakens
Pap Mark Dig, 2006, 11 (11-12):
[48] Experimental Test of the Educational Impact of the Newly Proposed FDA Graphic Cigarette Warnings Among US Adults
Magnan, Renee E.
Hamilton, W. Kyle
Shorey-Fennell, Bethany
Cameron, Linda D.
ANNALS OF BEHAVIORAL MEDICINE, 2021, 55 (04) : 298 - 307
[49] Type 2 diabetes combination treatment approved by US FDA
Ward, Ian
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2011, 6 (01) : 9 - 9
[50] Boxed Warnings and Other FDA Communication Tools
Marks, Norman S.
Weiss, Karen
AMERICAN FAMILY PHYSICIAN, 2010, 81 (03) : 259 - 260

← 1 2 3 4 5 →